These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1850540)

  • 1. Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome.
    Sumaya CV
    Rev Infect Dis; 1991; 13 Suppl 1():S19-25. PubMed ID: 1850540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus.
    Jones JF
    Rev Infect Dis; 1991; 13 Suppl 1():S26-31. PubMed ID: 1850541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.
    Swanink CM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM
    Clin Infect Dis; 1995 May; 20(5):1390-2. PubMed ID: 7620030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.
    Kawai K; Kawai A
    Intern Med; 1992 Mar; 31(3):313-8. PubMed ID: 1319246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
    Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
    Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
    Manian FA
    Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Epstein-Barr virus in patients with chronic fatigue.
    Matthews DA; Lane TJ; Manu P
    South Med J; 1991 Jul; 84(7):832-40. PubMed ID: 1648795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesviruses in chronic fatigue syndrome.
    Wallace HL; Natelson B; Gause W; Hay J
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):216-23. PubMed ID: 10066657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
    Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
    PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
    Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W
    Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
    Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
    PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic fatigue. A prospective clinical and virologic study.
    Gold D; Bowden R; Sixbey J; Riggs R; Katon WJ; Ashley R; Obrigewitch RM; Corey L
    JAMA; 1990 Jul; 264(1):48-53. PubMed ID: 2162397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
    Lerner AM; Dworkin HJ; Sayyed T; Chang CH; Fitzgerald JT; Beqaj S; Deeter RG; Goldstein J; Gottipolu P; O'Neill W
    In Vivo; 2004; 18(4):417-24. PubMed ID: 15369178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
    Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral infection and its causative role for chronic fatigue syndrome].
    Okano M
    Nihon Rinsho; 1992 Nov; 50(11):2617-24. PubMed ID: 1337559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
    Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
    J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic evaluation of 2', 5'-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan.
    Ikuta K; Yamada T; Shimomura T; Kuratsune H; Kawahara R; Ikawa S; Ohnishi E; Sokawa Y; Fukushi H; Hirai K; Watanabe Y; Kurata T; Kitani T; Sairenji T
    Microbes Infect; 2003 Oct; 5(12):1096-102. PubMed ID: 14554250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.